Cara Therapeutics (NASDAQ:TVRD) Coverage Initiated at Piper Sandler
Piper Sandler assumed coverage on shares of Cara Therapeutics (NASDAQ:TVRD – Free Report) in a research report released on Thursday morning, MarketBeat reports. The firm issued an overweight rating and a $78.00 price target on the stock. A number of other analysts also recently commented on TVRD. Wall Street Zen upgraded Cara Therapeutics to a […]
Piper Sandler assumed coverage on shares of Cara Therapeutics (NASDAQ:TVRD – Free Report) in a research report released on Thursday morning, MarketBeat reports. The firm issued an overweight rating and a $78.00 price target on the stock. A number of other analysts also recently commented on TVRD. Wall Street Zen upgraded Cara Therapeutics to a […]
